| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 75, 1333-1337, Copyright © 1992 by Endocrine Society
ARTICLES |
TM Goodwin, M Montoro, JH Mestman, AE Pekary and JM Hershman
Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.
Biochemical evidence of hyperthyroidism is frequently encountered in hyperemesis gravidarum, but its relationship to the cause of hyperemesis is unknown. We studied the relationship of serum hCG, thyroid function, and severity of vomiting among 57 hyperemesis patients and 57 controls matched for gestational age. TSH was suppressed in 60% of hyperemesis patients and 9% of controls. hCG correlated directly with free T4(r = 0.45, P < 0.001) and inversely with TSH (r = -0.48, P < 0.001). Hyperemesis patients had significantly greater mean serum hCG, free T4, total T3, and estradiol, and lesser serum TSH compared to controls. Hyperemesis patients with suppressed TSH had significantly greater free T4 and hCG compared to those with TSH in the normal range. Control and hyperemesis subjects were divided into four groups based on the severity of vomiting. The degree of biochemical hyperthyroidism and hCG concentration varied directly with the severity of vomiting. Unextracted serum was tested for thyrotropic activity by measuring its effect on iodide uptake in cultured FRTL-5 rat thyroid cells. Thyrotropic activity correlated with serum hCG (r = 0.50, P < 0.001). These data show that biochemical hyperthyroidism is a common finding in patients with hyperemesis gravidarum and suggest that hCG is the thyroid stimulator in this state. The increased estradiol concentration in patients with hyperemesis gravidarum may be attributed to the effects of hCG on steroidogenesis.
This article has been cited by other articles:
 |
|
 |
|
  D. Springer, T. Zima, and Z. Limanova Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy Eur. J. Endocrinol., May 1, 2009; 160(5): 791 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hershman The Role of Human Chorionic Gonadotropin as a Thyroid Stimulator in Normal Pregnancy J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3305 - 3306. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Haddow, M. R. McClain, G. Lambert-Messerlian, G. E. Palomaki, J. A. Canick, J. Cleary-Goldman, F. D. Malone, T. F. Porter, D. A. Nyberg, P. Bernstein, et al. Variability in Thyroid-Stimulating Hormone Suppression by Human Chronic Gonadotropin during Early Pregnancy J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3341 - 3347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Subsection Reports J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s8 - s47. [Full Text] [PDF]
|
|
|
|
|
|
M. Abalovich, N. Amino, L. A. Barbour, R. H. Cobin, L. J. De Groot, D. Glinoer, S. J. Mandel, and A. Stagnaro-Green Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s1 - s47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.F.G. Verberg, D.J. Gillott, N. Al-Fardan, and J.G. Grudzinskas Hyperemesis gravidarum, a literature review Hum. Reprod. Update, September 1, 2005; 11(5): 527 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rodien, N. Jordan, A. Lefevre, J. Royer, C. Vasseur, F. Savagner, A. Bourdelot, and V. Rohmer Abnormal stimulation of the thyrotrophin receptor during gestation Hum. Reprod. Update, March 1, 2004; 10(2): 95 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N K Kuscu and F Koyuncu Hyperemesis gravidarum: current concepts and management Postgrad. Med. J., February 1, 2002; 78(916): 76 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Fantz, S. Dagogo-Jack, J. H. Ladenson, and A. M. Gronowski Thyroid Function during Pregnancy Clin. Chem., December 1, 1999; 45(12): 2250 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F W F Hanna, J H Lazarus, and M F Scanlon Fortnightly review: Controversial aspects of thyroid disease BMJ, October 2, 1999; 319(7214): 894 - 899. [Full Text]
|
|
|
|
 |
|
 P. Rodien, C. Bremont, M.-L. R. Sanson, J. Parma, J. Van Sande, S. Costagliola, J.-P. Luton, G. Vassart, and L. Duprez Familial Gestational Hyperthyroidism Caused by a Mutant Thyrotropin Receptor Hypersensitive to Human Chorionic Gonadotropin N. Engl. J. Med., December 17, 1998; 339(25): 1823 - 1826. [Full Text] [PDF]
|
|
|
|
|
|
D. Fuhrer, P. Wonerow, H. Willgerodt, and R. Paschke Identification of a New Thyrotropin Receptor Germline Mutation (Leu629Phe) in a Family with Neonatal Onset of Autosomal Dominant Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4234 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Glinoer The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology Endocr. Rev., June 1, 1997; 18(3): 404 - 433. [Abstract] [Full Text]
|
|
|
|
 |
|
 The practical management of thyroid disease in pregnancy DTB, October 1, 1995; 33(10): 75 - 77. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
